Dysbiosis of the oral microbiota composition is associated with oral squamous cell carcinoma and the impact of radiotherapy: a pilot study

FEMS Microbiol Lett. 2023 Jan 17:370:fnad111. doi: 10.1093/femsle/fnad111.

Abstract

Radiotherapy can potentially influence the diversity and composition of the oral microbiome. We performed a study comparing the composition of oral microbiota in patients with oral squamous cell carcinoma (OSCC) before radiotherapy (n = 6), at three months (n = 6), and six months (n = 6) post-radiotherapy, and controls (n = 6). We profiled the oral microbiome by 16S rRNA gene sequencing using Illumina MiSeq. Alpha diversity (Chao1 index) showed significant differences in species richness between healthy controls and OSCC patients (P = 0.014). Conversely, no noteworthy distinctions were observed in the Chao1 index when comparing the pre-and post-radiation periods at both three and six months. The beta diversity of the oral microbiota differed significantly between the controls and OSCC patients (P = 0.014). However, no significant differences were observed in beta diversity between pre- and post-radiation at three months, whereas a significant difference was observed at six months (P = 0.038). Linear Discriminant Analysis Effect Size (LEfSe) demonstrated lower abundance of Corynebacterium, Actinomyces, Veillonella, and Haemophilus, and higher abundance of Selenomonas and Mycoplasma in OSCC patients than in healthy controls. The oral microbiome composition varied among healthy controls, patients with OSCC, and post-radiation therapy patients with OSCC. The observed recovery in the numerical dominance of specific beneficial oral taxa and the reduction in pathogenic bacteria after radiation therapy highlights the need for further investigations into their clinical implications.

Keywords: 16S rRNA gene sequencing; microbial biomarkers; microbiota; oral cancer; oral microbiome; oral squamous cell carcinoma; radiotherapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Squamous Cell* / complications
  • Carcinoma, Squamous Cell* / genetics
  • Carcinoma, Squamous Cell* / radiotherapy
  • Dysbiosis
  • Head and Neck Neoplasms* / complications
  • Head and Neck Neoplasms* / radiotherapy
  • Humans
  • Microbiota* / genetics
  • Mouth Neoplasms* / complications
  • Mouth Neoplasms* / genetics
  • Mouth Neoplasms* / radiotherapy
  • Pilot Projects
  • RNA, Ribosomal, 16S / genetics
  • Squamous Cell Carcinoma of Head and Neck / complications

Substances

  • RNA, Ribosomal, 16S